ChromaDex Corp
For the period ended Dec 31, 2023. Filed Mar 6, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 6, 2024
NAGE$2.15-5.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations for the Years Ended and
Consolidated Statements of Operations
(In thousands, except per share data)
| Year Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Sales, net | $83,570 | $72,050 |
| Cost of sales | 32,790 | 29,253 |
| Gross profit | 50,780 | 42,797 |
| Operating expenses: | ||
| Sales and marketing | 26,438 | 28,313 |
| Research and development | 4,958 | 4,826 |
| General and administrative | 24,983 | 28,286 |
| Total operating expenses | 56,379 | 61,425 |
| Operating loss | (5,599) | (18,628) |
| Nonoperating income: | ||
| Other income, net - Employee Retention Tax Credit | — | 2,085 |
| Interest income, net | 661 | 3 |
| Net loss | $(4,938) | $(16,540) |
| Basic and diluted loss per common share attributable to ChromaDex Corporation | $(0.07) | $(0.24) |
| Basic and diluted weighted average common shares outstanding | 74,985 | 69,729 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.